ArticleGynecology and minimally invasive therapy

Immunotherapy with Subcutaneous Injection of Immunomodulatory Agent (OK-432) Elicits Durable Response in Locally Advanced or Relapsed Cervical Cancer.

Quenny Michelle Dyan A Alas et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.